EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 30 (2023) Parasite, 30 (2023) 32 References
Open Access
Issue
Parasite
Volume 30, 2023
Article Number 32
Number of page(s) 11
DOI https://doi.org/10.1051/parasite/2023034
Published online 30 August 2023
  1. Abuaku B, Duah-Quashie NO, Quaye L, Matrevi SA, Quashie N, Gyasi A, Owusu-Antwi F, Malm K, Koram K. 2019. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017. Malaria Journal, 18(1), 1–12. [CrossRef] [PubMed] [Google Scholar]
  2. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han K-T, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ. 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 371, 411–423. [CrossRef] [PubMed] [Google Scholar]
  3. Ashley EA, Stepniewska K, Lindegårdh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F. 2007. How much fat is necessary to optimize lumefantrine oral bioavailability? Tropical Medicine & International Health, 12, 195–200. [CrossRef] [PubMed] [Google Scholar]
  4. CREAM. 2013. Monographie région Atsimo Atsinanana. Centre de recherches, d’etudes et d’appui à l’analyse économique à Madagascar (CREAM). (in French). https://www.pseau.org/outils/ouvrages/mg_mef_monographie-region-atsimo-atsinanana_2014.pdf. [Google Scholar]
  5. CREAM. 2013. Monographie région vatovavy fitovinany. Centre de recherches d’études et d’appui à l’analyse économique à Madagascar (CREAM). p. 12–26. [Google Scholar]
  6. Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, Félix J, Sanhangala E, Andrade BN, Santos Souza S, Talundzic E, Udhayakumar V, Owens C, Mbounga E, Wiesner L, Halsey ES, Martins JF, Fortes F, Plucinski MM. 2018. Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malaria Journal, 17(1), 144. [CrossRef] [PubMed] [Google Scholar]
  7. Dentinger CM, Rakotomanga TA, Rakotondrandriana A, Rakotoarisoa A, Rason MA, Moriarty LF, Steinhardt LC, Kapesa L, Razafindrakoto J, Svigel SS, Lucchi NW, Udhayakumar V, Halsey ES, Ratsimbasoa CA. 2021. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018. Malaria Journal, 20(1), 1–11. [CrossRef] [PubMed] [Google Scholar]
  8. Division of AIDS. 2014. Division of AIDS table for grading the severity of adult and pediatric adverse events. … of Allergy and Infectious Diseases. Division of AIDS. p. 1–21. [Google Scholar]
  9. Dorkenoo AM, Yehadji D, Agbo YM, Layibo Y, Agbeko F, Adjeloh P, Yakpa K, Sossou E, Awokou F, Ringwald P. 2016. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013. Malaria Journal, 15, 1–9. [CrossRef] [PubMed] [Google Scholar]
  10. Howes RE, Franchard T, Rakotomanga TA, Ramiranirina B, Zikursh M, Cramer EY, Tisch DJ, Kang SY, Ramboarina S, Ratsimbasoa A, Zimmerman PA. 2018. Risk factors for malaria infection in Central Madagascar: Insights from a cross-sectional population survey. American Journal of Tropical Medicine and Hygiene, 99, 995. [CrossRef] [PubMed] [Google Scholar]
  11. Ihantamalala FA, Rakotoarimanana FMJ, Ramiadantsoa T, Rakotondramanga JM, Pennober G, Rakotomanana F, Cauchemez S, Metcalf CJE, Herbreteau V, Wesolowski A. 2018. Spatial and temporal dynamics of malaria in Madagascar. Malaria Journal, 17, 1–13. [CrossRef] [PubMed] [Google Scholar]
  12. INSTAT, PNLP, IPM, USAID. 2016. Enquête sur les Indicateurs du Paludisme Madagascar. p. 161 p. https://dhsprogram.com/pubs/pdf/mis23/mis23.pdf. [Google Scholar]
  13. Kagoro FM, Barnes KI, Marsh K, Ekapirat N, Mercado CEG, Sinha I, Humphreys G, Dhorda M, Guerin PJ, Maude RJ. 2022. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. Lancet Microbe, 3, e184–e192. [CrossRef] [PubMed] [Google Scholar]
  14. Kesteman T, Rafalimanantsoa SA, Razafimandimby H, Rasamimanana HH, Raharimanga V, Ramarosandratana B, Ratsimbasoa A, Ratovonjato J, Elissa N, Randrianasolo L, Finlay A, Rogier C, Randrianarivelojosia M. 2016. Multiple causes of an unexpected malaria outbreak in a high-transmission area in Madagascar. Malaria Journal, 15, 1–6. [CrossRef] [PubMed] [Google Scholar]
  15. Konaté A, Barro PCM, Angora KE, Bédia-Tanoh AV, Djohan V, Kassi KF, Vanga-Bosson H, Miézan AJS, Assi SB, Menan EIH, Yavo W. 2018. Efficacy and tolerability of artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at two sentinel sites across Côte d’Ivore. Annals of Parasitology, 64(1), 49–57. [PubMed] [Google Scholar]
  16. Lendongo Wombo JB, Ibinga E, Oyegue-Liabagui SL, Imboumy Limoukou RK, Okouga AP, Mounioko F, Maghendji-Nzondo S, Lekana-Douki JB, Ngoungou EB. 2023. Severe malaria in children and adolescents in Southeast Gabon. BMC Infectious Diseases, 23, 207. [CrossRef] [PubMed] [Google Scholar]
  17. Maïga-Ascofaré O, May J. 2016. Is the A578S Single-nucleotide polymorphism in K13-propeller a marker of emerging resistance to artemisinin among Plasmodium falciparum in Africa? Journal of Infectious Diseases, 213, 165–166. [CrossRef] [PubMed] [Google Scholar]
  18. Ministère de la santé publique, Direction de lutte contre le paludisme. 2018. Plan stratégique nationale de lutte contre le paludisme Madagascar 2018–2022. https://pdf.usaid.gov/pdf_docs/PA00W977.pdf. [Google Scholar]
  19. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O. 2009. Randomized, multicentre assessment of the efficacy and safety of ASAQ–a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malaria Journal, 8(1), 1–12. [CrossRef] [PubMed] [Google Scholar]
  20. Nhama A, Bassat Q, Enosse S, Nhacolo A, Mutemba R, Carvalho E, Naueia E, Sevene E, Guinovart C, Warsame M, Sanz S, Mussa A, Matsinhe G, Alonso P, Tiago A, Macete E. 2014. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique, Malaria Journal, 13, 309. [CrossRef] [PubMed] [Google Scholar]
  21. Paczkowski M, Mwandama D, Marthey D, Luka M, Makuta G, Sande J, Ali D, Troell P, Mathanga DP, Gutman J. 2016. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014. Malaria Journal, 15, 1–10. [CrossRef] [PubMed] [Google Scholar]
  22. Premji ZG, Abdulla S, Ogutu B, Ndong A, Falade CO, Sagara I, Mulure N, Nwaiwu O, Kokwaro G. 2008. The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: A review of the evidence. Malaria Journal, 7, 1–7. [CrossRef] [PubMed] [Google Scholar]
  23. Programme Nationale de Lutte contre le Paludisme. 2017. Plan stratégique de lutte contre le paludisme Madagascar 2013-2017. https://apip.gov.gn/ficheprojet/1609762914.pdf. [Google Scholar]
  24. Ranford-Cartwright LC, Taylor J, Umasunthar T, Taylor LH, Babiker HA, Lell B, Schmidt- JR, Lehman LG, Walliker D, Kremsner PG. 1997. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 719–724. [CrossRef] [PubMed] [Google Scholar]
  25. Raobela O, Andriantsoanirina V, Rajaonera DG, Rakotomanga TA, Rabearimanana S, Ralinoro F, Ménard D, Ratsimbasoa A. 2018. Efficacy of artesunate-amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar. Malaria Journal, 17, 1–7. [CrossRef] [PubMed] [Google Scholar]
  26. Schmedes SE, Patel D, Dhal S, Kelley J, Svigel SS, Dimbu PR, Adeothy AL, Kahunu GM, Nkoli PM, Beavogui AH, Kariuki S, Mathanga DP, Koita O, Ishengoma D, Mohamad A, Hawela M, Moriarty LF, Samuels AM, Gutman J, Plucinski MM, Udhayakumar V, Zhou Z, Lucchi NW, Venkatesan M, Halsey ES, Talundzic E. 2021. Plasmodium falciparum kelch13 Mutations, 9 Countries in Africa, 2014–2018. Emerging Infectious Diseases, 27, 1902. [CrossRef] [PubMed] [Google Scholar]
  27. Seegenschmiedt MH. 1998. WHO – Toxicity Criteria, Nebenwirkungen in Der Onkologie. Internationale Systematik und Dokumentation. p. 30–34. [CrossRef] [Google Scholar]
  28. Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, Habimana RM, Rucogoza A, Moriarty LF, Sandford R, Piercefield E, Goldman I, Ezema B, Talundzic E, Pacheco MA, Escalante AA, Ngamije D, Mangala JLN, Kabera M, Munguti K, Murindahabi M, Brieger W, Musanabaganwa C, Mutesa L, Udhayakumar V, Mbituyumuremyi A, Halsey ES, Lucchi NW. 2021. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infectious Diseases, 21, 1120–1128. [CrossRef] [Google Scholar]
  29. WHO. 2009. Methods for surveillance of antimalarial drug efficacy. World Health Organization. p. 90. [Google Scholar]
  30. World Health Organization (WHO). 2014. Severe Malaria. Tropical Medicine & International Health, 19, 7–131. [CrossRef] [PubMed] [Google Scholar]
  31. WHO. n.d. Lignes directrices de l’OMS sur le paludisme – 16 février 2021. World health Organization. https://apps.who.int/iris/handle/10665/344167. [Google Scholar]
  32. WHO. n.d. Toxicity-grading-scale-for-determining-the-severity-of-clinical-adverse-events(1). World health Organization. [Google Scholar]
  33. Xie Y. 2020. The gender-related variability in the pharmacokinetics and antiplasmodial activity of naphthoquine in rodents. Malaria Journal, 19, 1–19. [CrossRef] [PubMed] [Google Scholar]
  34. Yavo W, Konaté A, Kassi FK, Djohan V, Angora EK, Kiki- PC, Vanga-Bosson H, Menan EIH. 2015. Efficacy and safety of artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sentinel sites across Côte d’Ivoire. Malaria Research and Treatment, 2015. [CrossRef] [Google Scholar]
  35. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D’Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, Den Broek, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M. 2009. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: A multi-centre analysis. Malaria Journal, 8, 1–18. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.